miRNA-216b通过靶向调控Beclin1对顺铂诱导的胃癌细胞自噬及凋亡的影响

周京涛; 刘佳; 李亮; 李建刚; 努尔买买提·阿米都拉; 闫军; 寇旭东; 艾孜买提·艾海提; 马博

doi:10.3969/j.issn.1671-038X.2021.06.04

miRNA-216b通过靶向调控Beclin1对顺铂诱导的胃癌细胞自噬及凋亡的影响

- 1. 新疆医科大学第七附属医院普外科(乌鲁木齐, 830000);
- 2. 新疆维吾尔自治区第八人民医院急诊科;
- 3. 新疆医科大学第二附属医院普外科
基金项目:
新疆维吾尔自治区卫生健康青年医学科技人才专项科研项目(No:WJWY-202006)

详细信息

通讯作者: 马博,E-mail:maboyang@sina.com

中图分类号: R735.2

收稿日期: 2021-03-06

Effect of miRNA-216b on autophagy and apoptosis of gastric cancer cells induced by cisplatin through targeted regulation of Beclin1

- 1. Department of General Surgery, Seventh Affiliated Hospital of Xinjiang Medical University, Urumqi, 830000, China;
- 2. Department of Emergency, Eighth People's Hospital of Xinjiang Uygur Autonomous Region;
- 3. Department of General Surgery, Second Affiliated Hospital of Xinjiang Medical University

More Information

Corresponding author: MA Bo, E-mail: maboyang@sina.com

Received Date: 06 March 2021

摘要

摘要: 目的:探究miRNA-216b(miR-216b)对顺铂处理的胃癌细胞的影响及其可能的作用机制。方法:体外培养人胃黏膜细胞系GES-1、人胃癌细胞系SGC7901和胃癌顺铂耐药细胞系SGC7901/DDP,将SGC7901/DDP细胞随机分为空白对照组、agomir-NC+oe-NC组、agomir-miR-216b+oe-NC组、agomir-miR-216b+oe-Beclin1组,按照分组进行细胞转染,荧光素酶报告实验检测miR-216b与Beclin1的靶向结合;qPCR检测细胞miR-216b的表达;Western blot检测细胞Beclin1、LC3、p62、Bax和Bcl-2蛋白表达;CCK-8检测细胞活力;克隆形成实验检测细胞增殖;流式细胞术检测细胞凋亡。结果:与GES-1组比较,SGC7901组细胞中miR-216b的表达显著降低(P<0.05),Beclin1蛋白表达显著升高(P<0.05);与SGC7901组比较,SGC7901/DDP组细胞中miR-216b的表达显著降低(P<0.05),Beclin1蛋白表达显著升高(P<0.05)。miR-216b靶向调控Beclin-1,与空白对照组比较,agomir-NC+oe-NC组SGC7901/DDP细胞中各指标差异无统计学意义;与agomir-NC+oe-NC组比较,agomir-miR-216b+oe-NC组SGC7901/DDP细胞中miR-216b的表达显著升高(P<0.05),Beclin1、LC3Ⅱ/LC3Ⅰ和Bcl-2蛋白表达显著降低(P<0.05),细胞活力和克隆数显著降低(P<0.05),细胞凋亡率、Bax和p62蛋白表达显著升高(P<0.05);与agomir-miR-216b+oe-NC组比较,agomir-miR-216b+oe-Beclin1组SGC7901/DDP细胞中Beclin1、LC3Ⅱ/LC3Ⅰ和Bcl-2蛋白表达显著升高(P<0.05),细胞活力和克隆数显著升高(P<0.05),细胞凋亡率、Bax和p62蛋白表达显著降低(P<0.05)。结论:miR-216b通过靶向调控Beclin1抑制自噬并促进凋亡,增加SGC7901/DDP细胞顺铂敏感性。
- 胃癌 /
- 顺铂 /
- miRNA-216b /
- Beclin1 /
- 自噬 /
- 凋亡
Abstract: Objective: To explore the effect of miR-216 b on gastric cancer cells treated with cisplatin and its possible mechanism.Methods: Human gastric mucosal cell line GES-1, human gastric cancer cell line SGC7901 and gastric cancer cisplatin-resistant cell line SGC7901/DDP were cultured in vitro. SGC7901/DDP cells were randomly divided into blank control group, agomir-NC+oe-NC group, agomir-miR-216 b+oe-NC group, agomir-miR-216 b+oe-Beclin1 group, the cells were transfected according to the groups, and the luciferase reporter experiment was used to detect the targeted binding of miR-216 b and Beclin1; qPCR was used to detect the expression of miR-216 b in cells; Western blot was used to detect the expression of Beclin1, LC3, p62, Bax, and Bcl-2 proteins in cells; CCK-8 was used to detect cell viability; clone formation experiments were used to detect cell proliferation; flow cytometry was used to detect apoptosis.Results: Compared with the GES-1 group, the expression of miR-216 b in the cells of the SGC7901 group was significantly reduced(P<0.05), and the expression of Beclin1 protein was significantly increased(P<0.05); compared with the SGC7901 group, the expression of miR-216 b in the cells of the SGC7901/DDP group was significantly reduced(P<0.05), and the expression of Beclin1 protein was significantly increased(P<0.05). miR-216 b regulates Beclin-1 expression through targeted binding. Compared with the blank control group, there was no statistically significant difference in the indicators of SGC7901/DDP cells in the agomir-NC+oe-NC group(P>0.05); compared with agomir-NC+oe-NC group, the expression of miR-216 b in SGC7901/DDP cells in the agomir-miR-216 b+oe-NC group was significantly increased(P<0.05), and the expression of Beclin1, LC3Ⅱ/LC3Ⅰ and Bcl-2 protein was significantly decreased(P<0.05), cell viability and clone number were significantly reduced(P<0.05), cell apoptosis rate, expression of Bax and p62 protein were significantly increased(P<0.05); compared with agomir-miR-216 b+oe-NC group, the expression of Beclin1, LC3Ⅱ/LC3Ⅰ and Bcl-2 protein in SGC7901/DDP cells in agomir-miR-216 b+oe-Beclin1 group was significantly increased(P<0.05), cell viability and clone number were significantly increased(P<0.05), cell apoptosis rate, expression of Bax and p62 protein were significantly reduced(P<0.05).Conclusion: miR-216 b inhibits autophagy and promotes apoptosis through targeted regulation of Beclin1 to increase the cisplatin sensitivity of SGC7901/DDP cells.
- gastric cancer /
- cisplatin /
- miRNA-216b /
- Beclin1 /
- autophagy /
- apoptosis

HTML全文

参考文献(25)

[1]	Smyth EC,Nilsson M,Grabsch HI,et al.Gastric cancer[J].Lancet,2020,396(10251):635-648.
[2]	Venerito M,Vasapolli R,Rokkas T,et al.Gastric cancer:epidemiology,prevention,and therapy[J].Helicobacter,2018,23(1):e125-e133.
[3]	Wagner AD,Syn NL,Moehler M,et al.Chemotherapy for advanced gastric cancer[J].Cochrane Database Syst Rev,2017,8(8):40-48.
[4]	Saha S,Panigrahi DP,Patil S,et al.Autophagy in health and disease:A comprehensive review[J].Biomed Pharmacother,2018,104(2):485-495.
[5]	王浩,刘巧丽,伏杰,等.至真方抑制自噬改善大肠癌HCT-116/L-OHP细胞耐药性\[J\].中国中西医结合消化杂志,2019,27(2):9-13,18.
[6]	Xin L,Zhou Q,Yuan YW,et al.METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy[J].J Cancer Res Clin Oncol,2019,145(10):2507-2517.
[7]	Lu TX,Rothenberg ME.MicroRNA[J].J Allergy Clin Immunol,2018,141(4):1202-1207.
[8]	Yang D,Xu T,Fan L,et al.microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis[J].J Exp Clin Cancer Res,2020,39(1):201-213.
[9]	Charalampakis N,Economopoulou P,Kotsantis I,et al.Medical management of gastric cancer:a 2017 update[J].Cancer Med,2018,7(1):123-133.
[10]	Ghosh S.Cisplatin:The first metal based anticancer drug[J].Bioorg Chem,2019,88(5):102-110.
[11]	Lyons K,Le LC,Pham YT,et al.Gastric cancer:epidemiology,biology,and prevention:a mini review[J].Eur J Cancer Prev,2019,28(5):397-412.
[12]	Doherty J,Baehrecke EH.Life,death and autophagy[J].Nat Cell Biol,2018,20(10):1110-1117.
[13]	Yang J,Zhou R,Ma Z.Autophagy and Energy Metabolism[J].Adv Exp Med Biol,2019,1206(2):329-357.
[14]	Onorati AV,Dyczynski M,Ojha R,et al.Targeting autophagy in cancer[J].Cancer,2018,124(16):3307-3318.
[15]	Xi Z,Si J,Nan J.LncRNA MALAT1 potentiates autophagy-associated cisplatin resistance by regulating the microRNA-30b/autophagy-related gene 5 axis in gastric cancer[J].Int J Oncol,2019,54(1):239-248.
[16]	Tutar L,Özgür A,Tutar Y.Involvement of miRNAs and Pseudogenes in Cancer[J].Method Mol Biol,2018,1699(5):45-66.
[17]	张荣枝,廖超,李毅忠.小檗碱单体靶向微小RNA-515-5p基因对结直肠癌细胞增殖和凋亡作用的研究\[J\].中国中西医结合消化杂志,2020,28(11):9-15.
[18]	Jana S,Krishna M,Singhal J,et al.Therapeutic targeting of miRNA-216b in cancer[J].Cancer Lett,2020,484(7):16-28.
[19]	胡琼丹,胡柯琴,樊均明.miR-216b通过FGFR1调节肾透明细胞癌细胞增殖和侵袭研究\[J\].重庆医学,2018,47(25):3245-3248.
[20]	Cai X,Xiao W,Shen J,et al.Thiostrepton and miR-216b synergistically promote osteosarcoma cell cytotoxicity and apoptosis by targeting FoxM1[J].Oncol Lett,2020,20(6):391-402.
[21]	Pei ML,Zhao ZX,Shuang T.Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer[J].J Ovarian Res,2020,13(1):144-156.
[22]	Yu L,Chen Y,Tooze SA.Autophagy pathway:Cellular and molecular mechanisms[J].Autophagy,2018,14(2):207-215.
[23]	Hill SM,Wrobel L,Rubinsztein DC.Post-translational modifications of Beclin 1 provide multiple strategies for autophagy regulation[J].Cell Death Differ,2019,26(4):617-629.
[24]	Xu HD,Qin ZH.Beclin 1,Bcl-2 and Autophagy[J].Adv Exp Med Biol,2019,1206(4):109-126.
[25]	Yang X,Bai F,Xu Y,et al.Intensified Beclin-1 Mediated by Low Expression of Mir-30a-5p Promotes Chemoresistance in Human Small Cell Lung Cancer[J].Cell Physiol Biochem,2017,43(3):1126-1139.